This inventor holds 1 USPTO granted patent. Top assignees: Chugai Seiyaku Kabushiki Kaisha, University College London. Active years: 2014.
Company Filing History:
1 out of 985 
1 out of 119 
Years Active: 2014
Title: Yong Kwee: Innovator in Cancer Vaccine Development
Introduction
Yong Kwee is a notable inventor based in London, GB, recognized for his contributions to the field of cancer research. He has developed innovative solutions aimed at improving cancer treatment through vaccine technology. His work has the potential to significantly impact the lives of patients battling cancer.
Latest Patents
Yong Kwee holds a patent for HM1.24, which focuses on utilizing cancer vaccines. This patent describes a cancer vaccine that contains as an active ingredient an antigen-specific dendritic cell pulsed by an HM1.24 protein, HM1.24 peptide, or transduced with an HM1.24-encoding gene, or HM1.24 protein-encoding DNA or RNA. This innovative approach aims to enhance the effectiveness of cancer vaccines.
Career Highlights
Throughout his career, Yong Kwee has worked with prominent organizations, including Chugai Seiyaku Kabushiki Kaisha and University College London. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Yong Kwee has collaborated with notable colleagues such as Yasuo Koishihara and Masaaki Kosaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in cancer research.
Conclusion
Yong Kwee's work in cancer vaccine development exemplifies the importance of innovation in medical research. His contributions have the potential to change the landscape of cancer treatment and improve patient outcomes.